Vinblastine: all 87 studies that test it

Page 1 of 1. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.

• Nivo40-AVD for Advanced Classic Hodgkin LymphomaRecruitingNCT06984146Phase 2
• A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in IndiaRecruitingNCT06831370Phase 4
• Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin LymphomaRecruitingNCT06745076Phase 2
• Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade GliomasRecruitingNCT06381570Early Phase 1
• A Study of BV-AVD in People With Bulky Hodgkin LymphomaRecruitingNCT06377566Phase 2
• Drug Screening Using IMD in Bladder CancerEnrolling by invitationNCT06204614Early Phase 1
• Vinblastine for Leukoreduction in Newly Diagnosed AML and HyperleukocytosisRecruitingNCT05062278Phase 2
• First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)RecruitingNCT04638790Phase 3
• Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract CancerRecruitingNCT04628767Phase 2/3
• Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II StudyActive, not recruitingNCT03517137Phase 2Results posted
• Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin LymphomaCompletedNCT03331341Phase 1/2Results posted
• Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin LymphomaActive, not recruitingNCT03233347Phase 2Results posted
• A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin LymphomaActive, not recruitingNCT02979522Phase 1/2Results posted
• Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract CancerCompletedNCT02412670Phase 2Results posted
• S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder CancerCompletedNCT02177695Phase 2Results posted
• Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin LymphomaCompletedNCT01578967Not applicableResults posted
• Metronomic Therapy in Patients With Metastatic MelanomaTerminatedNCT01542255Phase 2Results posted
• Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin LymphomaCompletedNCT01476410Phase 2Results posted
• Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's DiseaseCompletedNCT01404936Phase 2Results posted
• Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic MelanomaCompletedNCT01196416Phase 1/2Results posted
• Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin LymphomaCompletedNCT01132807Phase 2Results posted
• Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin LymphomaCompletedNCT01118026Phase 2Results posted
• Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic MelanomaCompletedNCT00885534Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer.CompletedNCT00520403Phase 2Results posted
• Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial CancerCompletedNCT00506155Phase 2Results posted
• Biochemotherapy With Temozolomide for Metastatic MelanomaTerminatedNCT00505635Phase 2Results posted
• Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin LymphomaCompletedNCT00352027Phase 2Results posted
• Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic LeukemiaCompletedNCT00186875Phase 2Results posted
• Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of TumorsCompletedNCT00061893Phase 2Results posted
• Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell LymphomaCompletedNCT00059839Phase 3Results posted
• Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform NeurofibromasCompletedNCT00030264Phase 2Results posted
• Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate CancerTerminatedNCT00024167Phase 3Results posted
• S0008: Chemotherapy Plus Biological Therapy in Treating Patients With MelanomaCompletedNCT00006237Phase 3Results posted
• 4B951, Combination Chemotherapy in Treating Patients With Bladder CancerTerminatedNCT00005047Phase 3Results posted
• A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade GliomaActive, not recruitingNCT04576117Phase 3
• Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17Active, not recruitingNCT03755804Phase 2
• Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid TumorsTerminatedNCT03585465Phase 1/2
• Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients With Classical Hodgkin LymphomaCompletedNCT03580408Phase 2
• FIL Study on ABVD DD-DI as Upfront Therapy in HL.CompletedNCT03159897Phase 3
• Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung CancerCompletedNCT03092986Phase 4
• Bendamustine Study in Classical Hodgkin Lymphoma Patients Over 60 Treated by Prednisone, Vinblastine and DoxorubicinCompletedNCT02414568Phase 2
• Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS TumoursCompletedNCT02343718Phase 1
• Brentuximab Vedotin Followed by ABVD in Patients With Previously Untreated Hodgkin LymphomaStatus unknownNCT02275598Phase 2
• LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell HistiocytosisActive, not recruitingNCT02205762Phase 2/3
• Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young AdultsTerminatedNCT01887522Phase 2
• Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young AdultsCompletedNCT01884922Phase 1
• Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial CancerWithdrawnNCT01639521Phase 2
• A Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing soliD Tumours.CompletedNCT01285817Phase 2
• R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCLCompletedNCT01148446Phase 3
• Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS TumoursCompletedNCT01135563Phase 1
• Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung CancerCompletedNCT01134861Phase 3
• Surgery Alone or With CYC VBL and PRED or CVP Alone in Stage IA or IIA Nodular Lymphocyte-Predominant Hodgkin LymphomaCompletedNCT01088750Phase 4
• Adriamycin, Vinblastine, DTIC and Revlimid in Elderly Hodgkin Lymphoma PatientsCompletedNCT01056679Phase 1
• Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's LymphomaStatus unknownNCT00816959Phase 3
• Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's DiseaseStatus unknownNCT00797472Phase 2
• High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative PatientsCompletedNCT00784537Phase 2/3
• Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder CancerTerminatedNCT00635726Phase 2
• Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs)Status unknownNCT00575796Phase 2
• Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and CisplatinTerminatedNCT00516750Phase 2
• PVAG-14 Pilot for Intermediate Stages Hodgkin LymphomaTerminatedNCT00512980Phase 2
• Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other CancersCompletedNCT00498979Phase 1
• H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell HistiocytosisWithdrawnNCT00488605Phase 3
• Combination Chemotherapy in Treating Young Male Patients With Hodgkin's LymphomaCompletedNCT00398554Phase 2
• Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade GliomaCompletedNCT00352495Phase 1
• HD11 for Intermediate StagesCompletedNCT00264953Phase 3
• Combination Chemotherapy +/- Radiation in High Risk Hodgkin's DiseaseTerminatedNCT00225173Phase 2
• Vinblastine and Methotrexate in Children With Pulmonary Vein StenosisCompletedNCT00215046Phase 2
• Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade GliomaCompletedNCT00213278Phase 2
• Large Cell Lymphoma Pilot Study IIICompletedNCT00187070Not applicable
• Study for Treatment of Cancer in Children With Ataxia-telangiectasiaCompletedNCT00187057Not applicable
• Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's LymphomaCompletedNCT00147875Phase 1/2
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's LymphomaCompletedNCT00086801Phase 2
• A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 YearsCompletedNCT00079105Phase 2
• Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell TumorsTerminatedNCT00072215Phase 3
• Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate CancerCompletedNCT00030654Phase 3
• Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder UrotheliumCompletedNCT00028756Phase 3
• Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the UrotheliumCompletedNCT00014274Phase 2/3
• Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's DiseaseCompletedNCT00004010Phase 2
• Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the UrotheliumCompletedNCT00003376Phase 3
• Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00003181Phase 2
• Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate CancerCompletedNCT00003084Phase 2
• Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic MelanomaCompletedNCT00003027Phase 3
• Vinblastine and Methotrexate in Treating Children With Desmoid TumorsCompletedNCT00003019Phase 2
• Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With MelanomaCompletedNCT00002882Phase 3
• Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate CancerCompletedNCT00002855Phase 3
• SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's DiseaseCompletedNCT00002495Phase 3
• A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal CancerCompletedNCT00001570Phase 1

← Vinblastine overview